Why is Indo US Bio-Tech falling/rising?

As of 01-Aug, Indo US Bio-Tech Ltd is experiencing a decline in its stock price, currently at Rs 168.30, which represents a decrease of Rs 6.9 or 3.94%. The stock has underperformed its sector by 4.25% today and has fallen after two consecutive days of gains. The stock touched an intraday low of Rs 168.3, and the weighted average price indicates that more volume was traded closer to this low price. Despite a strong long-term performance with a 272.96% increase over three years and a 799.21% increase over five years, the stock has faced significant challenges, including a year-to-date decline of 46.57%. Positive factors such as high management efficiency, a low Debt to EBITDA ratio, and consistent growth in operating profit and net sales have not been sufficient to counteract the recent downward trend.
In the broader market context, the stock's short-term performance over the past week shows a decline of 0.94%, which is slightly better than the Sensex's decline of 1.06%. However, the stock's year-to-date performance starkly contrasts with the Sensex, which has gained 3.15% during the same period. The falling investor participation, indicated by a decrease in delivery volume, suggests a lack of confidence among investors, which may be contributing to the stock's current downward movement. Overall, while the company has demonstrated strong fundamentals, the recent price action reflects a challenging market environment and investor sentiment.